Close

Aptevo Therapeutics (APVO) PT Lowered to $1.70 at Piper Sandler, Following Sale of IXINITY Hemophilia B Therapy

February 28, 2020 3:52 PM EST Send to a Friend
Piper Sandler analyst Edward A ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login